Giant Cell Arteritis (GCA) is a systemic vasculitis of the medium and large sized vessels with a tendency to involve extracranial branches of the carotid arteries .GCA is 2–3 times more common in females than males and occurs in over 50 years of age. Introduction. Presented as a poster at BSR Conference 2015. Rheumatology (Oxford) 2010 ; 49 : 1594 - 7 . This guideline is intended for doctors and allied health professionals who work in a primary or secondary care setting and manage patients with suspected and/or established Giant cell arteritis. Active GCA (see BSR Guidelines for GCA) Inflammatory: RA other arthropathies SLE, myopathies, other CTDs Non-inflammatory: Local shoulder and hip conditions Fibromyalgia/pain syndromes Step 3 Low-dose steroids Prednisolone 15–20 mg daily Clinical response in 1 week At least 70% global improvement Lab. doi: 10.1093/rheumatology/keq039a pmid: 20371504 OpenUrl CrossRef PubMed Web of Science 1. 2010 Aug;49(8):1594-7. doi: 10.1093/rheumatology/keq039a. resolution in 3–4 Step 4 BSR and BHPR guidelines for the management of giant cell arteritis Rheumatology (Oxford). Giant cell arteritis (GCA) is the most common ... guidelines for GCA.1 Questions related to how diagnosis was made (signs and symptoms) and how the GP managed British Society for Rheumatology (BSR) and the British Health Professionals in Rheumatology (BHPR) have recently published guidelines on the management of PMR. By Sarah Mackie and Peter Lanyon. BSR and BHPR guidelines for the management of giant cell arteritis. The British Society for Rheumatology (BSR) and the British Health Professionals in Rheumatology (BHPR) have recently published guidelines on the management of PMR. Accreditation is valid for 5 … Epub 2010 Apr 5. Key words: giant cell arteritis, temporal arteritis, large-vessel vasculitis, guidelines, investigations, diagnosis, treatment NICE has accredited the process used by the BSR to produce its guideline on the diagnosis and treatment of giant cell arteritis. British Society for Rheumatology has released its latest guideline on giant cell arteritis. The British Society for Rheumatology (BSR) and the British Health Professionals in Rheumatology (BHPR) have recently published guidelines on the management of PMR. 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis Annals of the Rheumatic Diseases doi: 10.1136/annrheumdis-2018-214755 Published Online First: 21 March 2019 Read recommendation See slide deck BSR and BHPR guidelines for the management of giant cell arteritis. The British Society for Rheumatology clinical practice guidelines on giant cell arteritis: five years in the making.